EBD GmbH is part of the Knowledge & Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring EBD Group BIO BIO-Europe Spring
Share/Follow Us
Share this:
Follow this event:

BIO-Europe Spring® 2016 Press Releases

July 30, 2014Spotlight on Stockholm/Uppsala Region Business Facts The Stockholm-Uppsala region, defined as the three counties of Uppsala, Stockholm and Sörmland, is one of the largest life science clusters in Europe. Stockholm-Uppsala region is Scandinavia's leading life science cluster and one of the world's most productive, and is one of the most competitive business environments in Europe. On average, an astounding 15–20 new...  more ►

partnering360:Insight Latest headlines from partnering360:Insight

October 9, 2015 Quintiles: Expanding options for emerging companies Executives at small, or emerging, biopharmaceutical companies often think their only viable options are to out-license products to larger players or to be acquired. Quintiles, a leading biopharmaceutical services provider, says there is an alternative. Working with a full-service provider can provide specific expertise on-demand, without adding staff to the payroll. more ►

October 7, 2015 MSD: Opportunities in animal and human collaborations Collaborating with animal health drug developers isn't a common developmental strategy for human pharmaceutical development, but it offers benefits worth considering—for both parties. Working at the intersection of human and animal health can potentially shorten time to commercialization by improving the understanding of the underlying science and by providing early notice of potential issues. more ►

September 22, 2015 Serodus advances novel cardiovascular and metabolic treatments to out-licensing Five compounds in the pipeline in just five years since Professor Eva Steiness became CEO, two already in Phase II trials. And having established a stable financial base, thanks to a listing on the Oslo Axess stock exchange, Serodus is now entering a partnering mode, according to Dr. Jürgen Langhärig, VP for Business Development. He arrives at BIO-Europe in Munich with a sharp focus on initiating out-licensing discussions. more ►

September 22, 2015 Shanghai CPGJ Pharma steps up to partnering at BIO-Europe 2015 Introducing itself for the first time at BIO-Europe 2015 in Munich, Shanghai CPGJ uniquely holds the largest monoclonal antibody production capacity in China and has been awarded four national high-tech industrialization enterprises. Shanghai CP GuoJian Pharmaceutical Company looks forward to meeting potential partners for strategic alliances in target markets. more ►

August 29, 2015 HSCI fosters broad collaboration At the Harvard Stem Cell Institute (HSCI), "Partnering is important at all levels," emphasized Brock Reeve, executive director. That impetus is important not just in the sciences, but also among foundations, large and small companies and investors throughout the life sciences community. more ►

Arrow Up

Follow this event:
Sign up now
For news and updates

Privacy Policy and Cookies Terms of Use

Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2015 EBD GmbH
Privacy Policy and Cookies
Terms of Use